Publication | Open Access
Down‐regulation of the cyclin‐dependent kinase inhibitor p57 is mediated by Jab1/Csn5 in hepatocarcinogenesis
49
Citations
40
References
2015
Year
Jab1-p57 pathway confers resistance to chemotherapy and may represent a potential target for investigational therapy in HCC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1